Literature DB >> 3875344

Calcium binding to a human factor IXa derivative lacking gamma-carboxyglutamic acid: evidence for two high-affinity sites that do not involve beta-hydroxyaspartic acid.

T Morita, W Kisiel.   

Abstract

A derivative of human blood clotting factor IXa beta lacking gamma-carboxyglutamic acid (Gla) residues was prepared by limited proteolysis with chymotrypsin, and subsequently examined for its ability to bind calcium ions. By amino acid analysis, Gla-domainless human factor IXa beta contained 0.3-0.4 moles of beta-hydroxyaspartic acid per mole of protein. Equilibrium dialysis experiments demonstrated that Gla-domainless human factor IXa beta retained two high-affinity calcium binding sites (Kd=52 microM), a finding essentially identical to that observed for Gla-domainless bovine factor IX that contains 0.8-0.9 moles of beta-hydroxyaspartic acid per mole of protein. These data strongly suggest that the beta-hydroxyaspartic acid residue in these proteins does not participate in their high affinity calcium sites.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875344     DOI: 10.1016/0006-291x(85)90493-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Occurrence of beta-hydroxylated asparagine residues in non-vitamin K-dependent proteins containing epidermal growth factor-like domains.

Authors:  C T Przysiecki; J E Staggers; H G Ramjit; D G Musson; A M Stern; C D Bennett; P A Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.

Authors:  William E Plautz; Vijaya Satish Sekhar Pilli; Brian C Cooley; Rima Chattopadhyay; Pamela R Westmark; Todd Getz; David Paul; Wolfgang Bergmeier; John P Sheehan; Rinku Majumder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02-01       Impact factor: 8.311

3.  Identification of the oligosaccharide structures of human coagulation factor X activation peptide at each glycosylation site.

Authors:  H Nakagawa; N Takahashi; K Fujikawa; Y Kawamura; M Iino; H Takeya; H Ogawa; K Suzuki
Journal:  Glycoconj J       Date:  1995-04       Impact factor: 2.916

4.  The first EGF-like domain from human factor IX contains a high-affinity calcium binding site.

Authors:  P A Handford; M Baron; M Mayhew; A Willis; T Beesley; G G Brownlee; I D Campbell
Journal:  EMBO J       Date:  1990-02       Impact factor: 11.598

5.  Recombinant human protein C derivatives: altered response to calcium resulting in enhanced activation by thrombin.

Authors:  H J Ehrlich; B W Grinnell; S R Jaskunas; C T Esmon; S B Yan; N U Bang
Journal:  EMBO J       Date:  1990-08       Impact factor: 11.598

6.  The role of beta-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IX.

Authors:  D J Rees; I M Jones; P A Handford; S J Walter; M P Esnouf; K J Smith; G G Brownlee
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.